Your browser doesn't support javascript.
loading
Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer.
Akamatsu, Hiroaki; Murakami, Eriko; Oyanagi, Jun; Shibaki, Ryota; Kaki, Takahiro; Takase, Eri; Tanaka, Masanori; Harutani, Yuhei; Yamagata, Nao; Okuda, Yuka; Furuta, Katsuyuki; Sugimoto, Takeya; Teraoka, Shunsuke; Hayata, Atsushi; Tokudome, Nahomi; Ozawa, Yuichi; Mori, Keita; Koh, Yasuhiro; Yamamoto, Nobuyuki.
Affiliation
  • Akamatsu H; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Murakami E; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Oyanagi J; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Shibaki R; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Kaki T; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Takase E; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Tanaka M; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Harutani Y; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Yamagata N; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Okuda Y; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Furuta K; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Sugimoto T; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Teraoka S; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Hayata A; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Tokudome N; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Ozawa Y; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Mori K; Clinical Trial Management Department, Shizuoka Cancer Center, Shizuoka, Japan.
  • Koh Y; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Oncologist ; 25(4): e679-e683, 2020 04.
Article in En | MEDLINE | ID: mdl-32297443
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug-Related Side Effects and Adverse Reactions / Lung Neoplasms / Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug-Related Side Effects and Adverse Reactions / Lung Neoplasms / Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication: